Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6151
Ceco Environmental
CECO
$3.85B
| $17K | ﹤0.01% |
2,667
-5,278
| -66% | -$29K |
|
6152
Civista Bancshares
CIVB
$604M
| $17K | ﹤0.01% |
735
-1,626
| -69% | -$38.8K |
|
6153
Clarus
CLAR
$123M
| $17K | ﹤0.01% |
2,110
-2,782
| -57% | -$20K |
|
|
CTO
6154
CTO Realty Growth
CTO
$824M
| $17K | ﹤0.01% |
1,050
-1,938
| -65% | -$32K |
|
6155
Goosehead Insurance
GSHD
$2.2B
| $17K | ﹤0.01% |
+717
| New | +$13.9K |
|
6156
PUT
Halozyme
HALO
$9.79B
| $17K | ﹤0.01% |
1,000
-169,100
| -99% | -$3.2M |
|
6157
Innovative Industrial Properties
IIPR
$1.71B
| $17K | ﹤0.01% |
471
-9,329
| -95% | -$320K |
|
6158
Larimar Therapeutics
LRMR
$397M
| $17K | ﹤0.01% |
141
-1,599
| -92% | -$136K |
|
6159
PUT
Macerich
MAC
$7.33B
| $17K | ﹤0.01% |
300
-256,600
| -100% | -$14.6M |
|
6160
Omega Flex
OFLX
$297M
| $17K | ﹤0.01% |
213
-1,173
| -85% | -$81.6K |
|
6161
CALL
Oxford Industries
OXM
$566M
| $17K | ﹤0.01% |
200
-100
| -33% | -$8.06K |
|
|
PDS
6162
CALL
Precision Drilling
PDS
$999M
| $17K | ﹤0.01% |
250
-1,230
| -83% | -$82.6K |
|
6163
PUT
ProShares Ultra QQQ
QLD
$12.7B
| $17K | ﹤0.01% |
1,600
-291,200
| -99% | -$3.02M |
|
6164
Rockwell Medical
RMTI
$28.4M
| $17K | ﹤0.01% |
32
-162
| -84% | -$97.1K |
|
6165
Cartesian Therapeutics
RNAC
$229M
| $17K | ﹤0.01% |
44
-53
| -55% | -$18.8K |
|
6166
Tilly's
TLYS
$116M
| $17K | ﹤0.01% |
1,130
-2,171
| -66% | -$27.6K |
|
6167
Teekay Tankers
TNK
$2.75B
| $17K | ﹤0.01% |
1,798
-3,484
| -66% | -$31.6K |
|
6168
PUT
CVR Partners
UAN
$1.36B
| $17K | ﹤0.01% |
510
-730
| -59% | -$21.8K |
|
6169
Village Super Market
VLGEA
$651M
| $17K | ﹤0.01% |
602
-1,183
| -66% | -$33.3K |
|
6170
PUT
Vistra
VST
$50B
| $17K | ﹤0.01% |
+715
| New | +$16.4K |
|
6171
Weyco Group
WEYS
$372M
| $17K | ﹤0.01% |
483
-909
| -65% | -$32.2K |
|
6172
Willdan Group
WLDN
$1.04B
| $17K | ﹤0.01% |
575
-1,027
| -64% | -$29.6K |
|
6173
XTI Aerospace
XTIA
$57.3M
| – | – |
0
| – | – |
|
|
ICD
6174
DELISTED
Independence Contract Drilling, Inc.
ICD
| $17K | ﹤0.01% |
211
-191
| -48% | -$16.4K |
|
|
GOL
6175
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $17K | ﹤0.01% |
3,200
+3,063
| +2,236% | +$27.7K |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,614 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.